Società Tekmira Pharmaceuticals Corporation Toronto S.E.
Azioni
TKM
CA87911B2093
Prodotti farmaceutici
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 39 | 100,0 % | 18 | 100,0 % | -53,51% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 39 | 100,0 % | 18 | 100,0 % | -53,51% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 50 | 01/07/14 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 11/06/18 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/04/17 |
Michael Sofia
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/03/15 |
John Naftzger
CMP | Compliance Officer | 57 | 10/07/23 |
Investor Relations Contact | - | 21/09/21 | |
Shannon Briscoe
HRO | Human Resources Officer | - | 01/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 68 | 01/12/14 | |
James Meyers
BRD | Director/Board Member | 59 | 23/10/18 |
Daniel Burgess
BRD | Director/Board Member | 62 | 23/03/17 |
Keith Manchester
BRD | Director/Board Member | 55 | 04/03/15 |
Frank Torti
CHM | Chairman | 45 | 26/11/18 |
Chief Executive Officer | 50 | 01/07/14 | |
Director/Board Member | 54 | 12/07/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 188 717 409 | 146 657 129 ( 77,71 %) | 0 | 77,71 % |
Coordinate società
![Indirizzo Tekmira Pharmaceuticals Corporation(TKM)](https://cdn.zonebourse.com/static/address/1411938.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+5,37% | 97,06 Mrd | |
+7,24% | 41,54 Mrd | |
-8,64% | 33,89 Mrd | |
+83,27% | 29,78 Mrd | |
-12,89% | 15,63 Mrd | |
-0,46% | 13,66 Mrd | |
-12,22% | 11,43 Mrd | |
+173,60% | 10,37 Mrd | |
+4,64% | 9,14 Mrd |